ArticleTherapeutic advances in neurological disorders2025

Clinical and mechanistic effects of cladribine in relapsing multiple sclerosis: 2-year results from the MAGNIFY-MS Study.

Klaus Schmierer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.